BioXcel Therapeutics, Inc.
BTAIDrugs in Pipeline
6
Phase 3 Programs
2
Upcoming Catalysts
1
Next Catalyst
Aug 11, 2026
13dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
BTAI Earnings Report
EPS Est: $-0.50 | FQ end 2026-06
How BTAI's past catalysts played out
BXCL501
Agitation,Psychomotor
Sublingual film containing dexmedetomidine (BXCL501)
Agitation
BXCL501 Sublingual Film
Bipolar I Disorder
BXCL701 plus Pembrolizumab
Prostate Cancer
Dexmedetomidine
Opioid Withdrawal
Sublingual film containing Dexmedetomidine
Agitation,Psychomotor
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
BXCL501 | Phase 3 | Agitation,Psychomotor | - | - |
Sublingual film containing dexmedetomidine (BXCL501) | Phase 3 | Agitation | - | - |
BXCL501 Sublingual Film | Phase 2 | Bipolar I Disorder | - | - |
BXCL701 plus Pembrolizumab | Phase 2 | Prostate Cancer | - | - |
Dexmedetomidine | Phase 2 | Opioid Withdrawal | - | - |
Sublingual film containing Dexmedetomidine | Phase 2 | Agitation,Psychomotor | - | - |
Agitation,Psychomotor
2 drugs in this indication
Agitation
2 drugs in this indication
Bipolar I Disorder
1 drug in this indication
Prostate Cancer
1 drug in this indication
Opioid Withdrawal
1 drug in this indication
Agitation Associated With Bipolar Disorder
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in BioXcel Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 6 drug candidates in BioXcel Therapeutics, Inc.'s (BTAI) pipeline across Phase 3, Phase 2. Its lead program is BXCL501 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is BioXcel Therapeutics, Inc.'s next FDA catalyst?→
BioXcel Therapeutics, Inc.'s (BTAI) next tracked catalyst is a Earnings expected August 11, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track BTAI biotech catalysts?→
Add BTAI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow BioXcel Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.